By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019

Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at

Key Statistics

Ownership: Private

Web Site: Crown Bioscience, Inc.



Company News
Crown Bioscience, Inc. Launches MuScreen Platform For Evaluating In Vivo Efficacy Of Immuno-Oncology Agents 4/26/2016 8:08:07 AM
Crown Bioscience, Inc. To Showcase Scientific Expertise At AACR 4/12/2016 7:36:20 AM
Crown Bioscience, Inc. Strengthens Immuno-oncology Capabilities With HuGEMM 4/5/2016 10:24:31 AM
Crown Bioscience, Inc. Licenses Its HuBase PDX Management Software 3/29/2016 9:43:26 AM
Crown Bioscience, Inc. Acquires PreClinOmics, Expands Cardiovascular and Metabolic Disease Portfolio 3/8/2016 10:36:21 AM
Crown Bioscience, Inc. To Commercialize University of York’s Prostate Cancer Models For Drug Development 2/11/2016 9:24:36 AM
Crown Bioscience, Inc. To Hold Symposium On Precision Medicine And Translating Oncology Drug Discovery Into Success In The Clinic 1/28/2016 9:47:17 AM
Crown Bioscience, Inc. Names Global Scientific Director For Translational Oncology 1/13/2016 9:08:36 AM
Crown Bioscience, Inc. Announces Establishment Of NASH Monitoring With Its Translational Models 12/16/2015 8:14:37 AM
Crown Bioscience, Inc. Expands Capacity In Europe And Invests In New Service Platforms 12/3/2015 10:14:46 AM